Aspergillus species are the major life threatening fungal pathogens in transplant patients. Germination of inhaled fungal spores initiates infection, causes severe pneumonia, and has a mortality of > 50%. This is leading to the consideration of pre-exposure prophylaxis to prevent infection. We made a very low MWt amphotericin B-polymethacrylic acid nanoparticle. It was not toxic to lung epithelial cells or monocyte-derived-macrophages in-vitro, or in an in-vivo transplant immuno-suppression mouse model of life threatening invasive aspergillosis. Three days of nebuliser based prophylaxis delivered the nanoparticle effectively to lung and prevented both fungal growth and lung inflammation. Protection from disease was associated with > 99% killing of the Aspergillus and a 90% reduction in lung TNF-α; the primary driver of tissue destructive immuno-pathology. This study provides in-vivo proof-of-principle that very small and cost-effective nanoparticles can be made simply, and delivered safely and effectively to lung by the aerosol route to prevent fungal infections.
From the Clinical Editor
Aspergillus is an opportunistic pathogen, which affects immunocompromised patients. One novel way to help fight against this infection is pre-exposure prophylaxis. The authors here made PMA based anionic hydrogels carrying amphotericin B, with mucoadhesive behavior. They showed that aerosol route of the drug was very effective in protecting against the disease in an in-vivo model and should provide a stepping-stone towards clinical trials in the future.
Graphical abstract
Nebulised nanoparticle prevents invasive aspergillosis. Aspergillus species are the major life threatening fungal pathogens in transplant patients. They cause severe pneumonia with mortality of > 50%. Preventing infection is therefore being explored. This very low MWt amphotericin B-polymethacrylic acid nanoparticle was given as an aerosol to a transplant immuno-suppression mouse model with life threatening invasive aspergillosis. Protection was associated with > 99% killing of the Aspergillus and a 90% reduction in lung TNF-α related inflammation. Simple and cost-effective pre-exposure prophylaxis prevents invasive lung fungal infections.
